Matrix metallopropteinases in heart failure.
Heart failure (HF) represents a complex multifactorial syndrome, characterized by crucial structural and functional abnormalities of the myocardium. Matrix metalloproteinases are associated with left ventricular dysfunction, adverse left ventricular remodelling and prognosis after acute myocardial i...
Hlavní autoři: | Tousoulis, D, Kampoli, A, Papageorgiou, N, Antoniades, C, Siasos, G, Latsios, G, Tsiamis, E, Stefanadis, C |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2012
|
Podobné jednotky
-
Matrix metalloproteinases in acute coronary syndromes: current perspectives.
Autor: Kampoli, A, a další
Vydáno: (2012) -
Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease.
Autor: Briasoulis, A, a další
Vydáno: (2012) -
Circulating biomarkers for the diagnosis and prognosis of heart failure.
Autor: Tousoulis, D, a další
Vydáno: (2009) -
Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.
Autor: Gounari, P, a další
Vydáno: (2010) -
C-reactive protein and endothelial dysfunction: gazing at the coronaries.
Autor: Tousoulis, D, a další
Vydáno: (2011)